Jefferies Financial Group Cuts Foghorn Therapeutics (NASDAQ:FHTX) Price Target to $14.00

Foghorn Therapeutics (NASDAQ:FHTX – Free Report) had its price objective decreased by Jefferies Financial Group from $18.00 to $14.00 in a report released on Monday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. FHTX has been the topic of a number of other reports. Evercore ISI began coverage on Foghorn Therapeutics […]

Leave a Reply

Your email address will not be published.

Previous post Mizuho Cuts Vital Energy (NYSE:VTLE) Price Target to $37.00
Next post Gisèle Pelicot’s ex-husband found guilty of rapes, sentenced to 20 years in prison in France